Jan 14 (Reuters) - Cardinal Health ( CAH ) said on
Tuesday it expects annual profit to be at the higher end of its
previous forecast range, primarily driven by strong demand for
costly specialty medicines and branded drugs at its
pharmaceuticals unit.
The company had said in November it expects an adjusted
per-share profit of $7.75 to $7.90 for the fiscal year ending
June 2025.